Myriad Genetics, Inc. (NASDAQ:MYGN)
Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Well run company with minimal debt. All star board of directors. The future will eventually be preventative medicine, and this company is an early mover in that field.
Recs
Recs
Their genetic marker will be a big help to drugmakers targeting patients specifically receptive to their treatments.
It may take a little longer than hoped because of choices the big pharmas made in how they test their therapies, but it ultimately seems Myriad will be the winner.
The pullback gives investors a nice entry point here.
Recs
so much competitors
Recs
ice and again ice
Recs
Watchlist
81 73 66
85 72 29
Recs
http://www.bloggingstocks.com/2010/11/19/myriad-genetics-mygn-speculating-on-cancer-diagnosis/
Rapid growth and a low PE, in what will soon be the fastest growing industry in the world.
Recs
bad background for MYGN...until 2012...
Recs
MYGN buys MYGN, others stay away ...
Recs
a long-term investment makes sense for those who plan to live many more years .... better if ever. MYGN loser is given until 2012
Recs
MYGN: Lowering Estimates - The firm has a Equal Weight rating and lowered its estimates through 2012
Recs
Events (facts), so far occurred, show that you should give confidence to the growth of MYGN. To date there are no facts that demonstrate a long-term growth of MYGN.La verification of an investment can be measured. MYGN must produce measurable data. MYGN must produce measurable data. MYGN not to build only news ...
Recs
Healthy income. Should be a top performer.
Recs
Young and old traders are rogues who suck the blood to others. they know they must die too, and perhaps to nemesis. MYGN has got good fondamentals but the traders do not consider it and continue to play the downside. No one should be more 'buy shares leave traders alone to kill each other. Shame!!!!!!!!!!!!
Recs
Why not???????????????????????
Recs
no comments...
Recs
Myriad Genetics(MYGN) is a biotechnonology company using the molecular biology to develop innovative diagnostic products. This company is a long-term BUY.
Kahuna, CFA
Retired Venture Capital
Portfolio Manager
Recs
If someone buys these shares and derives a benefit and at the same time confers an advantage on this stock, then that guy is smart. If someone buys these shares and gets a loss and at the same time someone else gets an advantage then that someone else is a bandit.
Recs
MYGN wants to change its name. This does not remove the disastrous recent past. Someone will undertake to remember that. MYRX will not be better than MYGN if it does not change its company policy.
Recs
June 11 2010: invalidated Myriad's patents. Now, it will collapse soon. I SUGGEST TO BUY TO 3 DOLLARS
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 129 : 1 2 3 4 5 6 7 Next »